Fulgent Genetics to Announce Second Quarter 2020 Financial Results on Tuesday August 4, 2020
July 14 2020 - 8:00AM
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the
“company”) today announced that it will release its second quarter
2020 financial results after the market closes on Tuesday August 4,
2020. The company’s Chairman and Chief Executive Officer Ming
Hsieh, Chief Financial Officer Paul Kim and Chief Commercial
Officer Brandon Perthuis will host a conference call for the
investment community the same day at 4:30 PM ET (1:30 PM PT) to
discuss the results and answer questions.
The call can be accessed through a live audio webcast in the
Investors section of the company’s website,
http://ir.fulgentgenetics.com, and through a live conference call
by dialing (855) 321-9535 using the conference ID 2797888. An audio
replay will be available in the Investors section of the company’s
website or by calling (855) 859-2056 using passcode 2797888 through
August 11, 2020.
About Fulgent Genetics
Fulgent Genetics is a growing technology company with an initial
focus on offering comprehensive genetic testing to provide
physicians with clinically actionable diagnostic information they
can use to improve the quality of patient care. The company has
developed a proprietary technology platform that integrates
sophisticated data comparison and suppression algorithms, adaptive
learning software, advanced genetic diagnostics tools and
integrated laboratory processes. This platform allows the company
to offer a broad and flexible test menu and continually expand and
improve its proprietary genetic reference library, while
maintaining accessible pricing, high accuracy and competitive
turnaround times. The company believes its current test menu, which
includes approximately 18,000 single-gene tests and more than 850
pre-established, multi-gene, disease-specific panels, offers more
genes for testing than its competitors in today’s market, which
enables it to provide expansive options for test customization and
clinically actionable results.
Investor Relations Contacts:The Blueshirt
GroupMelanie Solomon, 415-217-4964, melanie@blueshirtgroup.com
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Apr 2023 to Apr 2024